These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

40 related articles for article (PubMed ID: 9331782)

  • 21. Evaluation of bacterial polysaccharide immune globulin for the treatment or prevention of Haemophilus influenzae type b and pneumococcal disease.
    Siber GR; Thompson C; Reid GR; Almeido-Hill J; Zacher B; Wolff M; Santosham M
    J Infect Dis; 1992 Jun; 165 Suppl 1():S129-33. PubMed ID: 1588146
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Otitis media: prospects for prevention.
    Haggard M
    Vaccine; 2008 Dec; 26 Suppl 7():G20-4. PubMed ID: 19094934
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term protection after immunization with protein-polysaccharide conjugate vaccines in infancy.
    Blanchard-Rohner G; Pollard AJ
    Expert Rev Vaccines; 2011 May; 10(5):673-84. PubMed ID: 21604987
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Disease transmission: routes, contributing factors and herd immunity.
    O'Brien K
    Int J Clin Pract Suppl; 2001 Feb; (118):5-7. PubMed ID: 11715363
    [No Abstract]   [Full Text] [Related]  

  • 25. [Immunogenicity of Haemophilus Influenzae].
    Käyhty H
    Duodecim; 1996; 112(9):813-9. PubMed ID: 10592969
    [No Abstract]   [Full Text] [Related]  

  • 26. Current status and prospects for some improved and new bacterial vaccines.
    Robbins FC; Robbins JB
    Annu Rev Public Health; 1986; 7():105-25. PubMed ID: 3521639
    [No Abstract]   [Full Text] [Related]  

  • 27. Prevention of infections in hyposplenic and asplenic patients: an update.
    Melles DC; de Marie S
    Neth J Med; 2004 Feb; 62(2):45-52. PubMed ID: 15127830
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The impact of vaccines on pneumonia: key lessons from Haemophilus influenzae type b conjugate vaccines.
    Gessner BD; Adegbola RA
    Vaccine; 2008 Jun; 26 Suppl 2():B3-8. PubMed ID: 18793604
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Susceptibility to invasive bacterial infections in children with sickle cell disease.
    Battersby AJ; Knox-Macaulay HH; Carrol ED
    Pediatr Blood Cancer; 2010 Sep; 55(3):401-6. PubMed ID: 20232448
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunization of newborns with bacterial conjugate vaccines.
    van den Biggelaar AH; Pomat WS
    Vaccine; 2013 May; 31(21):2525-30. PubMed ID: 22728221
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Pneumococcal vaccination of splenectomized patients. Recommendations based on a 10-year experience].
    Konradsen HB; Henrichsen J
    Ugeskr Laeger; 1991 Oct; 153(43):2999-301. PubMed ID: 1801383
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The place of pneumococcal vaccination.
    Drug Ther Bull; 1998 Oct; 36(10):73-6. PubMed ID: 10194871
    [No Abstract]   [Full Text] [Related]  

  • 33. The immunocompromised host: immune alterations in splenectomized patients and clinical implications.
    Jirillo E; Mastronardi ML; Altamura M; Munno I; Miniello S; Urgesi G; Amati L
    Curr Pharm Des; 2003; 9(24):1918-23. PubMed ID: 12871175
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The pathogenesis of disease due to type b Haemophilus influenzae.
    Aubrey R; Tang C
    Methods Mol Med; 2003; 71():29-50. PubMed ID: 12374027
    [No Abstract]   [Full Text] [Related]  

  • 35. Bacterial vaccines for splenectomized patients.
    Kafidi KT; Rotschafer JC
    Drug Intell Clin Pharm; 1988 Mar; 22(3):192-7. PubMed ID: 3284730
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Protection against infections with Streptococcus pneumoniae and Haemophilus influenzae type B in a population of splenectomized individuals with varying vaccination status.
    Konradsen HB; Rasmussen C; Ejstrud P; Hansen JB
    Adv Exp Med Biol; 1997; 418():833-5. PubMed ID: 9331782
    [No Abstract]   [Full Text] [Related]  

  • 37. Global status of Haemophilus influenzae type b and pneumococcal conjugate vaccines: evidence, policies, and introductions.
    Levine OS; Knoll MD; Jones A; Walker DG; Risko N; Gilani Z
    Curr Opin Infect Dis; 2010 Jun; 23(3):236-41. PubMed ID: 20407316
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Conjugated pneumococcal vaccines].
    Reinert P
    Arch Pediatr; 1999; 6 Suppl 3():643s-646s. PubMed ID: 10429806
    [No Abstract]   [Full Text] [Related]  

  • 39. Optimising the use of conjugate vaccines to prevent disease caused by Haemophilus influenzae type b, Neisseria meningitidis and Streptococcus pneumoniae.
    Trotter CL; McVernon J; Ramsay ME; Whitney CG; Mulholland EK; Goldblatt D; Hombach J; Kieny MP;
    Vaccine; 2008 Aug; 26(35):4434-45. PubMed ID: 18617296
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immune responses to polysaccharides: lessons from humans and mice.
    González-Fernández A; Faro J; Fernández C
    Vaccine; 2008 Jan; 26(3):292-300. PubMed ID: 18160186
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]     [New Search]
    of 2.